Adverum Biotechnologies (ADVM)
(Delayed Data from NSDQ)
$2.95 USD
+0.07 (2.43%)
Updated Sep 18, 2025 04:00 PM ET
After-Market: $2.99 +0.04 (1.36%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Adverum Biotechnologies, Inc. has a market cap of $60.43M, which represents its share price of $2.88 multiplied by its outstanding shares number of 20.98M. As a small-cap company, ADVM's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
ADVM 2.95 +0.07(2.43%)
Will ADVM be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for ADVM based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ADVM
Adverum Biotechnologies (ADVM) Reports Q3 Loss, Tops Revenue Estimates
Adverum Biotechnologies (ADVM) Upgraded to Strong Buy: What Does It Mean for the Stock?
ADVM: What are Zacks experts saying now?
Zacks Private Portfolio Services
Zacks.com featured highlights Adverum Biotechnologies, IceCure, DarioHealth, Energous and Virgin Galactic
Bet on 5 Top-Ranked Stocks With Rising P/E
Other News for ADVM
Is ADVM building bearish momentum? Directional Movement Crossover Bearish shows up after sliding 4.64%
NR7 appears for ADVM after 1.63% move
Is ADVM showing downside potential? 20 Day Moving Average Resistance shows up after advancing 1.66%
Is ADVM building bearish momentum? Fell Below 20 Day Moving Average shows up after slipping 3.82%
Is ADVM likely to continue higher? Non-ADX 1,2,3,4 Bullish shows up after tumbling 5.14%